TEVA 5526 (Atazanavir Sulfate 150 mg)
Pill with imprint TEVA 5526 is Blue, Capsule-shape and has been identified as Atazanavir Sulfate 150 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Atazanavir is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 5526
Atazanavir Sulfate
- Imprint
- TEVA 5526
- Strength
- 150 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- Manufacturer
- Pliva Hrvatska d.o.o.
- National Drug Code (NDC)
- 00093-5526
- Inactive Ingredients
-
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
ferrosoferric oxide,
lactose monohydrate,
magnesium stearate,
propylene glycol,
shellac,
sodium lauryl sulfate,
sorbitan monolaurate,
titanium dioxide
Note: Inactive ingredients may vary.
More about atazanavir
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: protease inhibitors
- FDA Alerts (2)
Consumer resources
- Other brands
- Reyataz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.